Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2731-2735
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2731
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2731
Type of GI disorders | Functional effects | Mechanisms | Ref. |
Ulcer | Increases of cell proliferation, re-epithelialization and angiogenesis | Activation of growth factors and their receptors | [11,13-17] |
Inflammation | Decrease of pathogenic microbes, inflammatory cytokines and apoptosis; increase of mucus secretion | Activation of MAP kinase, formyl peptide receptor and mucin genes; electrostatic interaction on microbial membrane | [1,5,8,23] |
Cancer | Induction of apoptosis and cell cycle arrest | Release of AIF/EndoG; activation of BMPR and Smads | [29,30] |
- Citation: Chow JYC, Li ZJ, Kei WK, Cho CH. Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer. World J Gastroenterol 2013; 19(18): 2731-2735
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2731.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2731